Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 USD | -4.85% | -10.46% | +4.20% |
04-16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
04-16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
Sales 2024 * | 54.79M 4.37B | Sales 2025 * | 138M 11.03B | Capitalization | 84.99M 6.78B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.12B | Net income 2025 * | 11M 878M | EV / Sales 2024 * | 1.55 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.61 x |
P/E ratio 2024 * |
-5.71
x | P/E ratio 2025 * |
9.81
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | -4.85% | ||
1 week | -10.46% | ||
Current month | -27.20% | ||
1 month | -27.20% | ||
3 months | -4.66% | ||
6 months | +4.11% | ||
Current year | +4.20% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 14/06/09 |
Chief Operating Officer | 50 | 12-31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 30/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 31/05/09 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 14/06/09 |
Jason Barr
BRD | Director/Board Member | 44 | 31/05/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 4.71 | -4.85% | 59,961 |
25/04/24 | 4.95 | -2.17% | 12,151 |
24/04/24 | 5.06 | -1.94% | 15,554 |
23/04/24 | 5.16 | +5.31% | 16,630 |
22/04/24 | 4.9 | -6.84% | 62,107 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.20% | 84.99M | |
-16.99% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.80% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.42% | 1.03B |
- Stock Market
- Equities
- PRPH Stock